Search for: "ACTAVIS" Results 801 - 820 of 1,006
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Jul 2010, 9:59 pm
Click here for further details.The decision of the Court of Appeal for England and Wales in Actavis UK Limited v Novartis AG -- which has the distinction of being the most-commented-upon ruling ever to have been posted on this weblog -- was bound to be the subject of an appeal. [read post]
2 May 2017, 1:00 am by Matrix Legal Support Service
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
6 Dec 2018, 12:31 pm by John P. Feldman and Andrew Bernasconi
Actavis, 570 U.S. 136 (2013), parties entering into trademark settlements are not immune from antitrust liability. [read post]
4 Mar 2009, 11:00 pm
(Spicy IP) Kenya enacts Biosafety Act 2/2009 regulating activities in GMOs, establishing National Biosafety Authority (Afro-IP) US: BIO meets the press: economic health of the biotech industry; follow-on biologics; patent reform (Patent Docs) (Patent Docs) (Intellectual Property Watch) US: Obama touts generic biologics to lower drug costs (Law360) US: Genentech announces victory in Cabilly re-examination (Patent Docs) US: Federal judge rejects Scruggs family’s bid to reconsider summary… [read post]
15 May 2017, 1:00 am by Matrix Legal Support Service
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
13 Jan 2010, 3:00 am
Actavis Elizabeth LLC (Docket Report) US: Inclusion of Pay-for-Delay ban in Health Care Bill urged; FTC to hold press conference announcing pay-for-delay analysis (FDA Law Blog) US: Drug molecules going off patent in 2010 (Patentcircle)   Products Cipramil (Citalopram) - EU: Commission opens antitrust investigation into pharmaceutical company Lundbeck (EPLAW) (Managing IP) (GenericsWeb) Hectorol (Doxercalciferol) - US: Genzyme files patent infringement complaint against Cobrek in N D… [read post]
26 Nov 2018, 1:00 am by Matrix Legal Support Service
Actavis Group PTC EHF & Ors v ICOS Corporation & Anor, heard 19-20 Nov 2018. [read post]
24 Apr 2017, 1:00 am by Matrix Legal Support Service
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
8 Oct 2008, 10:13 am
While Aerotel placed a large wedge between the EPO Board of Appeals and English courts, recent cases have been bridging the gap, particularly in the area of obviousness in non-software cases (namely, Conor v Angiotech and Actavis v Merck). [read post]
20 Sep 2011, 6:35 am by Bexis
Actavis, Inc., ___ F.3d ___, 2011 WL 3659409 (5th Cir. [read post]
14 Jan 2010, 11:09 am by Guest Barista
Actavis Elizabeth LLC, 2-07-cv-03770 (NJD December 31, 2009, Amended Opinion (Cavanaugh, J.). [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three Copaxone-related patents… [read post]
5 Dec 2010, 3:02 pm
Next was Mr Justice Floyd, who considered the validity of intent-based claims – claims for products distinguished by the purpose or intent for which they are used, as discussed in Adhesive Dry Mounting (Ch 1910), Actavis v Merck (CA 2008) and Mobil/friction reducing additive (EBA 1989) – and the impact of claim categories on the inherent patentability of products more generally. [read post]
19 Nov 2018, 1:00 am by Matrix Legal Support Service
On Monday 19 and Tuesday 20 November, the Supreme Court will hear the appeal of Actavis Group PTC EHF & Ors v ICOS Corporation & Anor. [read post]
5 Feb 2019, 1:19 am by Philipp Widera
Based on the Pemetrexed-decision of the German Federal Supreme Court (docket-no X ZR 29/15, also known as Actavis v Eli Lilly), the Court of Appeal made it clear that Swiss-type claims are to be treated in the same way as so-called EPC 2000-claims. [read post]